InvestSMART

Adherium Limited (ASX: ADR) - Share Price

- Current share price for ADR : $0.100

Adherium Limited (ADR) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a provider of integrated digital health solutions and connected respiratory medical devices. Adherium's Hailie platform solution provides clinicians, healthcare providers and patients access to remotely monitor medication usage parameters and adherence, supporting reimbursement for qualifying patient management.

ADR General Information +

ASX Code ADR
Website http://www.adherium.com
Industry/Sector Health Care Technology
Market Cap ($M) 5
ADR Share Price $0.100
Day High $0.100
Day Low $0.100
Last Close $0.100
ADR Share Price Movement - ( No change )
Prices as at 12:45, 18 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Adherium Limited (ADR) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 3.25¢ 100% 15 Sep 2016 4 Oct 2016 - - -
Result 1.25¢ 100% 23 Mar 2016 7 Apr 2016 - - -

See all dividends from Adherium Limited (ADR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Adherium Limited (ADR) price-sensitive announcements

ADR - Adherium Announces CEO Transition
Adherium Limited, a leader in digital respiratory management, announced the transition of
Adherium Limited (ADR)
29 Jul 2026 | 12:06 PM
ADR - Quarterly Activities/Appendix 4C Cash Flow Report
Adherium Limited reported its Appendix 4C Quarterly Cash Flow for the quarter ending 30 Ju
Adherium Limited (ADR)
29 Jul 2026 | 8:29 AM
ADR - Adherium - Investor Update
Adherium Limited's investor update emphasizes its focus on refining patient enrollment str
Adherium Limited (ADR)
27 Jul 2026 | 8:32 AM
ADR - Adherium enters into short-term loan funding facility
Adherium Limited has secured a short-term unsecured loan of USD$1.65 million from its majo
Adherium Limited (ADR)
29 Jun 2026 | 1:45 PM

Adherium Limited (ADR) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Adherium Limited (ADR)
ORDINARY FULLY PAID
 Health Care $5 Adherium enters into additional $1M short-term loan facility 18 Aug 2026 8:57AM $0.100 $0.100 fallen by 0%
Adherium Limited (ADR)
ORDINARY FULLY PAID
 Health Care $5 Ceasing to be a substantial holder 30 Jul 2026 5:45PM $0.105 $0.100 fallen by 4.76%
Adherium Limited (ADR)
ORDINARY FULLY PAID
 Health Care $5 Adherium Announces CEO Transition 29 Jul 2026 12:06PM $0.105 $0.100 fallen by 4.76%
Adherium Limited (ADR)
ORDINARY FULLY PAID
 Health Care $5 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2026 8:29AM $0.105 $0.100 fallen by 4.76%
Adherium Limited (ADR)
ORDINARY FULLY PAID
 Health Care $5 Adherium - Investor Update 27 Jul 2026 8:32AM $0.105 $0.100 fallen by 4.76%
Adherium Limited (ADR)
ORDINARY FULLY PAID
 Health Care $5 Appendix 3Y - Capital Consolidation (4 Directors) 14 Jul 2026 4:28PM $0.130 $0.100 fallen by 23.08%

ADR Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$12.68 -$139.90 -29.40% 0.00 0.00 0.00% 0.0%
2024A -$10.22 -$198.30 -20.30% 0.00 0.00 0.00% 0.0%
2023A -$9.86 -$248.90 -53.20% 0.00 0.00 0.00% 0.0%

ADR Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
4DMedical Limited (4DX) $2,183M 0.3304 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Adherium Limited (ADR) $5M -0.2944 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $18,685M 0.3919 0.2545 0.2962 162.4523 129.4961 99.9050 0.31% 0.39% 0.51%

ADR Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -0.22 0.00
Market 0.30 13.10 1.16 0.67
Sector 0.75 19.20 1.63 2.17

ADR Directors

Name Position Start Date
Mr Louis (Lou) James Panaccio Non-Executive Director 25 Feb 2022
Mr Jeremy Curnock-Cook Non-Executive Director 17 Apr 2015
Mr Keven Gessner Non-Executive Director 8 May 2025
Ms Victoria Durrans Non-Executive Director 1 Jun 2026
Mr George Baran Non-Executive Director, Non-Executive Chairman 13 May 2021

Adherium Limited (ADR) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 Jun 2026 BARAN, George Issued Indirect Shares 105,331,536 $0.003 $315,994.608
22 Jun 2026 PANACCIO, Louis (Lou) Issued Indirect Shares 9,666,664 $0.003 $28,999.992
20 Mar 2026 BARAN, George Issued Indirect Shares 22,371,011 $0.005 $111,855.055

See all changes in directors' interest & trades for Adherium Limited (ADR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ADR Management

Name Position
Emily Austin Company Secretary
John Perry Interim CEO

ADR Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Adherium Limited (ADR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
364,651,488 (19.57%) Regal Funds Management Pty Limited
343,770,320 (18.45%) Phillip Asset Management Ltd
343,776,885 (18.45%) Trudell Medical Limited
208,172,938 (11.17%) UBS Group AG and its related bodies corporate
125,168,715 (6.72%) Bank of America Corporation and its related bodies corporate
106,836,248 (5.73%) K One W One Limited

ADR Calendar of Events

Date Event
26 February 2027 Report (Interim)
29 September 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.